Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006297

Enrollment

300

Registered

2014-07-11

Start date

2014-11-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancers of different origin C30-C39

Interventions

Group 1: Asservation of blood serum, plasma and whole blood at different time points before, during and after end of radiotherapy for biomarker analysis

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: NSCLC treated with stereotactic body radiotherapy or nomally fractionated radiotherapy. In addition, patients with cancers of different origin and treated with SBRT may also be included for biomarker analysis.

Exclusion criteria

Exclusion criteria: Postoperative radiotherapy. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Explorative biomarker analysis in blood serum, plasma and whole blood before, during and after radiotherapy	—

Countries

Switzerland

Contacts

Public ContactOliver Riesterer

Klinik für Radio-OnkologieUniversitätsSpital Zürich

oliver.riesterer@usz.ch+41 (0) 44 255 3748

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026